U.S. President Donald Trump on Thursday unveiled sweeping new import tariffs, including 100% duties on branded drugs and 25% levies on heavy-duty trucks, set to come into force next week.
The latest salvo, which Trump said was to protect the U.S. manufacturing industry and national security, follows wide-ranging duties on trading partners of up to 50% and other targeted levies on imported products such as steel.
It's the latest upheaval for global businesses already struggling with snarled supply chains, soaring costs and consumer uncertainty caused by Trump's trade war. The barrage has cast a pall over global growth, while the Federal Reserve has said it is also contributing to higher U.S. consumer prices.
Trump's announcement on Truth Social did not say whether the new levies would be on top of existing national tariffs. Recent trade deals with Japan, the EU, and Britain include provisions that cap tariffs for specific products like pharmaceuticals.
A non-binding preliminary trade deal between the EU and the U.S. agreed to limit tariffs to 15%. Trump hasn't yet signed an executive order confirming the agreement.
The European Commission said on Friday the agreement was "clear" that there was an all-inclusive 15% tariff ceiling, which represented "an insurance policy that no higher tariffs will emerge" for European companies.
Nathalie Moll, director general of the European Federation of Pharmaceutical Industries and Associations, said that urgent discussions were needed on "how to avoid any tariffs on medicines that harm patients in the EU and the U.S."
Japan has an agreement that its tariff rates will not exceed others including the EU, Tokyo's trade negotiator Ryosei Akazawa said.
DRUGMAKERS HAVE BEEN BRACING FOR TARIFFS
Trump said the 100% tariff on branded drugs would only apply to producers that had not already broken ground on U.S. manufacturing plants.
Many drugmakers have announced multibillion-dollar investments in the United States, and Switzerland's Roche underlined on Friday that one of its U.S. units recently started work on a new facility.
Rival Novartis, which has also made a large U.S. investment pledge, did not reply to a request for comment.
Switzerland is still discussing a trade agreement with the U.S. and its economy ministry said it was waiting for more details on Trump's latest announcement.
The Pharmaceutical Research and Manufacturers of America, an industry group, said companies "continue to announce hundreds of billions in new U.S. investments. Tariffs risk those plans."
Trump had long threatened higher tariffs on drugmakers and Ireland, where mainly American-owned pharmaceutical factories employ about 2% of the workforce, has frontloaded much of its exports to the U.S. in anticipation.
Exports of chemical and related products, including medicinal and pharmaceutical products, leapt 536% year-on-year to 23.9 billion euros ($27.9 billion) in the first seven months of 2025, according to Ireland's Central Statistics Office.
Trump also followed through on a pledge to "bring back" America's furniture business, saying he would start charging a 50% tariff on imported kitchen cabinets and bathroom vanities and a 30% tariff on upholstered furniture.
All the new duties take effect from October 1.
The new actions are seen as part of the Trump administration's shift to better-established legal authorities for its trade actions, given the risks associated with a case before the Supreme Court on the legality of his global tariffs.
Trump this week announced new probes into the national security ramifications of personal protective equipment, medical items, robotics and industrial machinery. He previously imposed national security tariffs on steel and aluminum and derivatives, light-duty autos and parts, and copper.
Trump has made the levies a key foreign policy tool, using them to renegotiate trade deals, extract concessions and exert political pressure on other countries.
His administration has played down the impact on consumer prices and touted tariffs as a significant revenue source, with Treasury Secretary Scott Bessent saying Washington could collect $300 billion by the end of the year.
Source: Investing.com
Initial jobless claims in the United States reached 232,000 for the week ending October 18, according to data from the US Department of Labor website. This represents a slight increase compared to the...
The global geopolitical situation is once again showing signs of escalation, particularly in the Asia-Pacific region. A ship collision between the Chinese Coast Guard and the People's Liberation Army ...
Most big emerging economies, including China, Brazil and India, can weather U.S. tariffs without excessive pain, a study by risk consultancy Verisk Maplecroft showed, raising doubt about the clout of ...
Even as a U.S.–China trade truce appears to be holding, analysts caution that the détente remains fragile in a rivalry increasingly defined by strategic competition. A flurry of decisions, outlined i...
The U.S. Senate is expected to hold a test vote on a spending bill on Sunday evening to end the longest ever U.S. government shutdown, with ABC News reporting that enough Democrats now supported the m...
Silver steadied around $51 as markets digested the Fed's October minutes which revealed a divided committee. Many officials still expect cuts at some point but a large group signalled that a December move is not certain, and that pullback in near...
US stocks finished higher on a volatile Wednesday session, reversing some of the sharp selling from the prior four sessions as markets digested a divisive Fed minutes release and awaited Nvidia's earnings after the close. The S&P 500 rose 0.4%...
A divided Federal Reserve cut interest rates last month even as many policymakers cautioned that lowering borrowing costs further could risk undermining the fight to quell inflation that has been above the U.S. central bank's 2% target for four and...
Asian stock markets opened cautiously at the start of the week, with the MSCI Asia Pacific index rising slightly by 0.2%. The Kospi led the gains,...
European markets opened lower on Tuesday (November 18th) as global markets weakened amid renewed concerns over AI-related stocks.
The pan-European...
Federal Reserve Vice Chair Philip Jefferson said on Monday the U.S. central bank needs to "proceed slowly" with any further interest rate cuts as it...
On Tuesday morning, November 18, 2025, sentiment on Asian markets remained cautious following a sharp decline on Wall Street and concerns about the...